Avantor increases manufacturing of single-use technology
Avantor plans to increase its manufacturing capability of single-use technologies for biologics and vaccines. Read More
Nikon debuts artificial intelligence-assisted confocal microscopes
Nikon has released its next-generation confocal microscope series, including the AX and AX R. The microscopes feature a redesigned scan head with 8192 x 8192-pixel resolution, ultrahigh-speed resonant scanning, and a 25-mm field-of-view. Read More
LogicBio signs collaborations with Daiichi Sankyo and Canbridge
LogicBio has signed separate collaboration and option agreements with Daiichi Sankyo and Canbridge Pharmaceuticals in China for the development of therapies based on LogicBio's GeneRide gene insertion platform. Read More
Immunome SARS-CoV-2 antibody cocktail neutralizes variants
Immunome said that preclinical testing shows that its IMM-BCP-01 antibody cocktail neutralizes SARS-CoV-2 variants of concern. Read More
Pieris licenses bispecific antibody to Boston Pharmaceuticals
Pieris Pharmaceuticals has licensed its preclinical PRS-342 bispecific immuno-oncology antibody to Boston Pharmaceuticals. Read More
Sanofi to provide fill/finish services for Moderna COVID-19 vaccine
Moderna has inked a new agreement with Sanofi in order to scale up U.S. manufacturing capacity for its COVID-19 vaccine. Read More
Following review, FDA lifts J&J COVID-19 vaccine pause
Johnson & Johnson's COVID-19 vaccinations are set to resume in the U.S. following a decision by the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention. Read More
Mediso completes acquisition of MRI spectrometer
Multimodality imaging technology provider Mediso Medical Imaging Systems has purchased the intellectual property for Cameleon4, a magnetic resonance imaging spectrometer developed by longtime partner and French spectrometer firm RS2D. Read More
Life science investment firm commits $65M to drug discovery efforts
Deerfield Management and the Empire Discovery Institute have formed a research partnership to accelerate the development of therapeutics, with Deerfield investing up to $65 million over the next five years. Read More
Carlyle Group to acquire Unchained Labs for $435M
The Carlyle Group will acquire life science tools company Unchained Labs for $435 million. The transaction is expected to close in the second quarter of 2021. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
